1Sordilo L M, Shafer Wearer K, Derosa D. Immunobiology of mammary gland[J]. J Dairy Sei, 1997,80(8): 1851 - 1865.
2Dib M,zhao X,Wang X. Mast cells contribute to early Pancreatitis- induced systemic endothelial barrier dysfunction [J]. Pancreatology, 2002,(4)2:396 - 401.
3Dib M,zhao X,Wang X D. Role of mast cell in the development of pancreatitis - induced multiple organ dysfunction [J]. Br J Surg, 2002, 89(2): 172 - 178.
4Yonetci N, Oruc N, Ozutemiz A O, et al. Effects of mast - cell stabilization in cerulein - induced acute pancreatitis in rats [J]. Int J Pancreatol,2001, 29(3): 163- 171.
5FoxCC, LichtensteinLM, Roche J K.Intestinal mast cell responses in idiopathic inflammatory bowel disease. Histamine release from human intestinal mast cells in response to gut epithelial proteins [J]. Dig Dis Sci,1993,38(6): 1105- 1112.
6Stoyanova I I , Gulubova M V. Mast cells and inflammatory mediators in chronic ulcerative colitis [J] . Acta Histochem, 2002, 104(2): 185 -192.
7Nishida Y , Murase K , Isomoto H, et al .Different distribution of mast cells and macrophages in colonic mucosa of patients with collagenous colitis and inflammatory bowel diseae [J]. Hepatogastroenterology, 2002, 49(45) :678 - 682.
8Goldman A S, Chheda S, Garofalo R. Evolution of immunologic function of the mammary gland and the postnatal devdopment of immunity [J].Pediatr Res , 1998,43:155 - 162.
9Srivastava M D,Srivastava B I. Soluble fas and soluble fas ligand proteins in human milk:possible significance in the development of immunological tolerance [J]. Scandinavian Journal of Immunology, 1999,49:51-54.
10McDermott M R, Bienenstoch J. Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory and genital tissues[J]. J Immunol, 1979,122:1892.
二级参考文献25
1[1]Church MK, Bradding P, Walls AF, et al. Human mast cells and basophils. In allergy and allergic diseases[M]. by AB Kay, Blackwell, Oxford. 1997:149-170.
2[2]Okayama Y, Church MK. Comparison of the modulatory effect of ketotifen, sodium cromoglycate, procaterol and salbutamol in human skin, lung and tonsil mast cells[J]. Int Arch Allergy Appl Immunol, 1992, 97:216-222.
3[3]Okayama Y, Benyon RC, Lowman MA, et al. In vitro effects of H1-antihistamine and PGD2 release from mast cells of human lung, tonsil and skin[J]. Allergy, 1994, 49:246-253.
4[4]Butchers PR, Vardey CJ, Johnson M. Salmeterol: a potent and long-acting inhibitor of inflammatory mediator release from human lung[J]. Br J Pharmacol, 1991, 104:672-676.
5[5]Naclerio R, Kagey-Sobotka MA, Lichtenstein LM, et al. Terfenadine, an H1 antihistamine, inhibits histamine release in vivo in the human[J]. Am Rev Respir Dis, 1990, 142:167-171.
6[6]He S, Gaca MDA, Walls AF. A role for tryptase in the activation of human mast cells: modulation of histamine release by tryptase and inhibitors of tryptase[J]. J Pharmacol Exp Ther, 1998, 286:289-297.
7[7]Clark JM, Abraham WM, Fishman CE, et al. Tryptase inhibitors block allergen-induced airway and inflammatory responses in allergic sheep[J]. Am J Respir Crit Care Med, 1995, 152:2076-2083.
8[8]Burgess LE, Newhouse BJ, Ibrahim P, et al. Potent selective nonpeptidic inhibitors of human lung tryptase[J]. Proc Natl Acad Sci USA, 1999, 96:8348-8352.
9[9]Buckley MG, Variend S, Walls AF. Elevated serum concentrations of beta-tryptase, but not alpha-tryptase, in sudden infant death syndrome (SIDS). An investigation of anaphylactic mechanisms[J]. Clin Exp Allergy, 2001, 11:1696-1704.
10[10]Church MK, Hiroi J. Inhibition of IgE-dependent histamine release from dispersed lung mast cells by anti-allergic drugs and salbutamol[J]. Br J Pharmacol, 1987, 90:421-429.
